words lines 0 60 0 20 top 50% bottom top 1 0 0 .22 back 1 0 .001 1 .1 1.5 none top bottom center center true 1 none top top center top true 0 200 .001 none
top bottom top center true 1 none top bottom bottom bottom true 1 none

CEO Raman Singh speaks about his mission to bring accessibility to the core of pharmaceutical innovation while being committed to ESG.

Oct 12, 2022

Juniper Biologics

Author


Mind Your Business: Striking a balance between pharmaceutical innovation and accessibility to medication

The pharmaceutical industry has gone through heaps and bounds of multiple shake ups due to the Covid-19 pandemic. And as we move forward, it has become more important than ever to strike a balance between pharmaceutical innovation and accessibility to medication.

Raman Singh, Chief Executive Officer, Juniper Biologics shares with us on how his company are looking ways to support Singapore’s efforts to be the next frontier in pharmaceutical services. 

M&A Awards 2023
Juniper Biologics Clinches Prestigious Molecular Science & Technology Acquisition of the Year Award at the Acquisition International M&A Awards 2023
1703238629922
Juniper Therapeutics Acquires Exclusive Rights for SAR Registration for Anti-Viral COVID-19 Drug from Ping An-Shionogi Hong Kong for Singapore
GHP Most Innovative Oncology Pharmaceutical Company 2023
Singapore-based Juniper Biologics Awarded the Most Innovative Oncology Pharmaceutical Company 2023 by GHP Healthcare and Pharmaceutical Awards
Follow us on Facebook